The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s actinic keratosis treatment market report forecasts the actinic keratosis treatment market size to grow to $3.89 Billion by 2027, with a CAGR (compound annual growth rate) of 7%.

Learn More On The Actinic Keratosis Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/actinic-keratosis-treatment-global-market-report

Actinic Keratosis Treatment Market Size Forecast
The global actinic keratosis treatment market is expected to grow from $2.75 billion in 2022 to $2.98 billion in 2023 at a compound annual growth rate (CAGR) of 8.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The actinic keratosis treatment market is expected to grow to $3.89 billion in 2027 at a CAGR of 7%.

North America held the largest actinic keratosis treatment market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Actinic Keratosis Treatment Market Driver ­– Growth In The Prevalence Of Actinic Keratosis
For instance, in February 2022, according to the article by World Cancer Research Fund International, a UK-based organization, there were more than 150,000 new cases of actinic keratosis in 2020, which increased to 197,700 cases in 2022. Therefore, the growing prevalence of actinic keratosis drives the actinic keratosis treatment market.

Request for A Sample Of The Global Actinic Keratosis Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8283&type=smp

Key Actinic Keratosis Treatment Market Trend – Product Innovations
Major companies operating in the market are introducing innovative products to sustain their position in the actinic keratosis treatment market. For instance, in July 2021, Almirall, a US-based pharmaceutical company, got approval for Klisyri (tirbanibulin), a topical microtubule inhibitor and an innovative topical treatment for actinic keratosis (AK). This is a topical first-in-class microtubule inhibitor that acts through a selective antiproliferative mechanism of action applicable for adults for the usage on the face or scalp.

Actinic Keratosis Treatment Market Segment
1) By Treatment: Topical Treatment, Procedural Modality, Photodynamic Therapy, and Other Treatments
2) By Medication: Flurouracil Cream, Imiquimod Cream, Ingenol Mebutate Gel, Diclofenac Gel
3) By End User: Hospitals, Private Dermatology Clinics, Laser Therapy Centers, Cancer Treatment Centers, Spas and Rejuvenation Centers, Homecare

Actinic Keratosis Treatment Market Major Players and Strategies
Major players in the actinic keratosis treatment market are Sun Pharmaceutical Industries Ltd., Novartis AG, Hill Dermaceuticals, Inc., Bausch Health Companies, Inc., LEO Pharma A/S, Almirall, S.A., Biofrontera AG, Bioforntera AG, Galderma S.A., Mylan N.V., Cipher Pharmaceuticals Inc., Stanford Chemicals, Galderma S.A., GlaxoSmithKline plc., Pierre Fabre Pharmaceuticals Inc., and Tolmar Pharmaceuticals.

In October 2020, DermBiont, a US-based company advancing targeted topical therapeutics, acquired SeylanMED for an undisclosed amount. The acquisitions’ aim to treat skin illnesses at their source is reflected in our therapeutic pipeline, which includes a first-in-class, targeted topical small molecule. SeylanMED is a US-based biotech company that develops a targeted therapy for seborrheic and actinic keratosis.

The Actinic Keratosis Treatment Global Market Report 2023 covers regional data on actinic keratosis treatment market size, actinic keratosis treatment market trends and drivers, opportunities, strategies, and actinic keratosis treatment market competitor analysis. The countries covered in the actinic keratosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Actinic keratoses treatment refers to a treatment done for actinic keratoses, a skin disease that appears on the face, scalp, backs of the hands, or chest as a result of sun exposure. This treatment decreases the risk of developing the skin condition by keeping the skin protected from ultraviolet (UV) rays and limiting regular exposure to the sun.

View More Reports Related To The Actinic Keratosis Treatment Market –
Skin Care Products Global Market Report 2023
Dermatitis Global Market Report 2023
Lotions (Including Sunscreens) Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: